Why is Mankind Pharma falling/rising?

As of 18-Sep, Mankind Pharma Ltd's stock price is rising, currently at Rs 2,635.00, reflecting an increase of Rs 69.1 or 2.69%. The stock has shown a trend reversal, gaining after five consecutive days of decline, and has outperformed its sector by 1.64%. It reached an intraday high of Rs 2,659.9, representing a 3.66% increase. Despite a year-to-date decline of 8.41%, the stock has performed well over the past year, with a return of 9.94%, while the broader market has only seen a slight increase of 0.08%. The company's strong fundamentals, including a high return on equity of 17.21%, a low debt-to-equity ratio, and healthy long-term growth in net sales and operating profit, contribute positively to its recent price movement.
In the broader market context, Mankind Pharma's short-term performance over the past week shows a return of 1.35%, which is slightly below the benchmark Sensex's return of 1.80%. However, the stock's ability to generate positive returns over the past year, despite the negative performance of the broader market, indicates resilience and strong institutional support, with holdings at 24.58%. This suggests that institutional investors, who typically have more resources to analyze company fundamentals, have confidence in Mankind Pharma's potential, which may be influencing the stock's upward movement.